Indication | Drug Discovery | Preclinical | Clinical Phase 1 | Clinical Phase 2 | Clinical Phase 3 | Release |
---|---|---|---|---|---|---|
Obesity | ||||||
Diabetes |
Code | Indication | Research | Pre-Clinical | Clinical Study | Marketing Authorization | Release |
---|---|---|---|---|---|---|
DKF-MA102 | Prostate cancer | |||||
DKF-MB101 | Immuosuppression | |||||
DKF-MA201 | Growth Hormone | |||||
DKF-MB201 | Growth Hormone | |||||
DKF-313 | Prostatic Hypertrophy | |||||
DKF-335 | Osteoporosis | |||||
DKF-460 | Dyslipidemia |
Code | Indication | Research | Pre-Clinical | Clinical Study | Marketing Authorization | Release |
---|---|---|---|---|---|---|
DKM-428 | Skin protection | |||||
DKB-119 | Tissue repair (Filler) | |||||
DKB-133 | Tissue repair (Filler) |